(Reuters) -British drugmaker GSK said on Wednesday it expects to report annual sales and profit towards the top end of its forecast range, adding that its outlook includes the impact of tariffs in place so far and expected levies on European goods.
The British drugmaker reported second-quarter sales and profit above analyst expectations, driven by strength in its specialty medicine business.
(Reporting by Pushkala Aripaka in Bengaluru and Maggie Fick in London; Editing by Subhranshu Sahu)
Comments